Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Immunopharmacology

Results: 1-25/168

Authors: Dedio, J Renne, T Weisser, M Muller-Esterl, W
Citation: J. Dedio et al., Subcellular targeting of multiligand-binding protein gC1qR, IMMUNOPHARM, 45(1-3), 1999, pp. 1-5

Authors: Higashida, H Taketo, M Takahashi, H Yokoyama, S Hashii, M
Citation: H. Higashida et al., Potential mechanism for bradykinin-activated and inositol tetrakisphosphate-dependent Ca2+ influx by Ras and GAP1 in fibroblast cells, IMMUNOPHARM, 45(1-3), 1999, pp. 7-11

Authors: Faussner, A Bathon, JM Proud, D
Citation: A. Faussner et al., Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation, IMMUNOPHARM, 45(1-3), 1999, pp. 13-20

Authors: Madeddu, P Salis, MB Emanueli, C
Citation: P. Madeddu et al., Altered baroreflex control of heart rate in bradykinin B-2-receptor knockout mice, IMMUNOPHARM, 45(1-3), 1999, pp. 21-27

Authors: Schanstra, JP Marin-Castano, ME Alric, C Pesquero, JB Claire, M Girolami, JP Bascands, JL
Citation: Jp. Schanstra et al., Homologous and heterologous induction of the human bradykinin B1-receptor and B1-receptor localisation along the rat nephron, IMMUNOPHARM, 45(1-3), 1999, pp. 29-34

Authors: Naraba, H Ueno, A Yoshimura, M Kosugi, Y Oh-ishi, S
Citation: H. Naraba et al., Examination of signal transduction pathway of stimulated B-1 and B-2 kininreceptors; MAP kinase pathway to AP-1 translocation in HEK 293 cells, IMMUNOPHARM, 45(1-3), 1999, pp. 35-38

Authors: Campos, AH Calixto, JB Schor, N
Citation: Ah. Campos et al., Effects of kinins upon cytosolic calcium concentrations in mouse mesangialcells, IMMUNOPHARM, 45(1-3), 1999, pp. 39-49

Authors: Takeda, H Kimura, Y Higashida, H Yokoyama, S
Citation: H. Takeda et al., Localization of B-2 bradykinin receptor mRNA in the rat retina and sclerocornea, IMMUNOPHARM, 45(1-3), 1999, pp. 51-55

Authors: Alric, C Pecher, C Bascands, JL Girolami, JP
Citation: C. Alric et al., Effect of bradykinin on tyrosine kinase and phosphatase activities and cell proliferation in mesangial cells, IMMUNOPHARM, 45(1-3), 1999, pp. 57-62

Authors: Shimuta, SI Barbosa, AMRB Borges, ACR Paiva, TB
Citation: Si. Shimuta et al., Pharmacological characterization of RMP-7, a novel bradykinin agonist in smooth muscle, IMMUNOPHARM, 45(1-3), 1999, pp. 63-67

Authors: Zuccollo, A Navarro, M Frontera, M Cueva, F Carattino, M Catanzaro, OL
Citation: A. Zuccollo et al., The involvement of kallikrein-kinin system in diabetes type I (insulitis), IMMUNOPHARM, 45(1-3), 1999, pp. 69-74

Authors: Frost, CL Naude, RJ Oelofsen, W Jacobson, B
Citation: Cl. Frost et al., Comparative blood coagulation studies in the ostrich, IMMUNOPHARM, 45(1-3), 1999, pp. 75-81

Authors: Rae, F Bulmer, B Nicol, D Clements, J
Citation: F. Rae et al., The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library, IMMUNOPHARM, 45(1-3), 1999, pp. 83-88

Authors: Ueno, A Naraba, H Kojima, F Morita, E Oh-ishi, S
Citation: A. Ueno et al., FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response, IMMUNOPHARM, 45(1-3), 1999, pp. 89-93

Authors: Podlich, D Kemme, M
Citation: D. Podlich et M. Kemme, Different susceptibility of human tissue prokallikrein to cleavage by neutrophil proteinases, IMMUNOPHARM, 45(1-3), 1999, pp. 95-101

Authors: Mashiko, H Miyamoto, K Takahashi, H
Citation: H. Mashiko et al., Cleavage of porcine high molecular weight kininogen by the action of porcine pancreatic kallikrein, IMMUNOPHARM, 45(1-3), 1999, pp. 103-105

Authors: Monsees, TK Miska, W Blocher, S Schill, WB Winkler, A Siems, WE
Citation: Tk. Monsees et al., Elements of the kallikrein-kinin system are present in rat seminiferous epithelium, IMMUNOPHARM, 45(1-3), 1999, pp. 107-114

Authors: dos Reis, ML Maeda, S Rosatelli, JB Donadi, EA Roselino, AMF
Citation: Ml. Dos Reis et al., Kininogens and kallikrein in pruritic papular eruption, IMMUNOPHARM, 45(1-3), 1999, pp. 115-120

Authors: Takano, M Horie, M Narahara, M Miyake, M Okamoto, H
Citation: M. Takano et al., Expression of kininogen mRNAs and plasma kallikrein mRNA by cultured neurons, astrocytes and meningeal cells in the rat brain, IMMUNOPHARM, 45(1-3), 1999, pp. 121-126

Authors: Shibuya, Y Semba, U Nishino, N Khan, MMH Tanase, S Okabe, H Yamamoto, T
Citation: Y. Shibuya et al., Primary structure of guinea pig plasma prekallikrein, IMMUNOPHARM, 45(1-3), 1999, pp. 127-134

Authors: Hermann, A Arnhold, M Kresse, H Neth, P Fink, E
Citation: A. Hermann et al., Expression of components of the kallikrein-kinin system in human cell lines, IMMUNOPHARM, 45(1-3), 1999, pp. 135-139

Authors: Wendel, HP Jones, DW Gallimore, MJ
Citation: Hp. Wendel et al., FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery, IMMUNOPHARM, 45(1-3), 1999, pp. 141-144

Authors: Oliva, MLV Andrade, S Batista, IFC Sampaio, MU Juliano, M Fritz, H Auerswald, EA Sampaio, CAM
Citation: Mlv. Oliva et al., Human plasma kallikrein and tissue kallikrein binding to a substrate basedon the reactive site of a factor Xa inhibitor isolated from Bauhinia ungulata seeds, IMMUNOPHARM, 45(1-3), 1999, pp. 145-149

Authors: Del Nery, E Chagas, JR Juliano, MA Juliano, L Prado, ES
Citation: E. Del Nery et al., Comparison of human and porcine tissue kallikrein substrate specificities, IMMUNOPHARM, 45(1-3), 1999, pp. 151-157

Authors: Sakamoto, W Nishikata, M Fujie, K Handa, H Nishihira, J
Citation: W. Sakamoto et al., T-kininogen and a 45 kDa proteinase from Porphyromonas gingivalis, IMMUNOPHARM, 45(1-3), 1999, pp. 159-162
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>